Author
Listed:
- Sen Xu
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710000, China
Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710000, China
Shaanxi Center for Health Reform and Development Research, Xi’an Jiaotong University, Xi’an 710000, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710000, China)
- Shengfang Yuan
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710000, China
Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710000, China
Shaanxi Center for Health Reform and Development Research, Xi’an Jiaotong University, Xi’an 710000, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710000, China)
- John Alimamy Kabba
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710000, China
Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710000, China
Shaanxi Center for Health Reform and Development Research, Xi’an Jiaotong University, Xi’an 710000, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710000, China)
- Chen Chen
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710000, China
Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710000, China
Shaanxi Center for Health Reform and Development Research, Xi’an Jiaotong University, Xi’an 710000, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710000, China)
- Wenchen Liu
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710000, China
Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710000, China
Shaanxi Center for Health Reform and Development Research, Xi’an Jiaotong University, Xi’an 710000, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710000, China)
- Jie Chang
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710000, China
Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710000, China
Shaanxi Center for Health Reform and Development Research, Xi’an Jiaotong University, Xi’an 710000, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710000, China)
- Yu Fang
(Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an 710000, China
Center for Drug Safety and Policy Research, Xi’an Jiaotong University, Xi’an 710000, China
Shaanxi Center for Health Reform and Development Research, Xi’an Jiaotong University, Xi’an 710000, China
Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China’s Western Technological Innovation Harbor, Xi’an 710000, China)
Abstract
Overuse of antibiotics has caused a series of global problems, especially in the underdeveloped western regions where healthcare systems are fragile. We used antibiotic procurement data of all healthcare institutions to analyze the total amount, patterns and trends of antibiotic use in Shaanxi Province, western China between 2015 and 2018. Antibiotic utilization was quantified using the standard Anatomical Therapeutic Chemical (ATC)/Defined daily dose (DDD) methodology. The World Health Organization’s “Access, Watch and Reserve” (AWaRe) classification and European Surveillance of Antimicrobial Consumption (ESAC) drug-specific quality indicators were also adopted to evaluate the appropriateness and quality of antibiotic utilization. Overall, antibiotic consumption decreased from 11.20 DID in 2015 to 10.13 DID (DDDs per 1000 inhabitants per day) in 2016, then increased to 12.99 DID in 2018. The top three antibiotic categories consumed in 2018 were J01C (penicillins) 33.58%, J01D (cephalosporins) 29.76%, and J01F (macrolides) 19.14%. Parenteral antibiotics accounted for 27.41% of the total consumption. The largest proportion of antibiotic use was observed in primary healthcare institutions in rural areas, which accounts for 51.67% of total use. Consumption of the Access group, the Watch group, the Reserve group of antibiotics was 40.31%, 42.28% and 0.11%, respectively. Concurrently, the consumption of J01D and the percentage of J01 (DD + DE) (third and fourth generation cephalosporins) were at a poor level according to the evaluation of ESAC quality indicators. The total antibiotic consumption in Shaanxi Province had been on an upward trend, and the patterns of antibiotic use were not justified enough to conclude that it was rational. This is partly because there was high preference for the third and fourth generation cephalosporins and for the Watch group antibiotics.
Suggested Citation
Sen Xu & Shengfang Yuan & John Alimamy Kabba & Chen Chen & Wenchen Liu & Jie Chang & Yu Fang, 2020.
"Analysis of Antibiotic Use Patterns and Trends Based on Procurement Data of Healthcare Institutions in Shaanxi Province, Western China, 2015–2018,"
IJERPH, MDPI, vol. 17(20), pages 1-13, October.
Handle:
RePEc:gam:jijerp:v:17:y:2020:i:20:p:7536-:d:429262
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:20:p:7536-:d:429262. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.